Evaluation of Corrected QT Intervals of 74 COVID19 Patients Treated with Hydroxychloroquine in Combination with or without Azithromycin and/or Favipiravir


UYAROĞLU O. A. , ŞENER Y. Z. , ÖZDEDE M., ÇALIK BAŞARAN N., ÖZIŞIK L., ŞAHİN T. K. , ...More

European Journal of Therapeutics, vol.27, no.4, pp.311-317, 2021 (Peer-Reviewed Journal) identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 4
  • Publication Date: 2021
  • Doi Number: 10.5152/eurjther.2021.21022
  • Journal Name: European Journal of Therapeutics
  • Journal Indexes: Emerging Sources Citation Index, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.311-317
  • Keywords: COVID-19, corrected QT, hydroxychloroquine, azithromycin, favipiravir, RISK

Abstract

Objective: We aimed to evaluate the degree of QTc prolongation and associated factors in patients with COVID-19 in association with their usage of hydroxychloroquine (HCQ) with or without the combination of azithromycin (AZ) and/or favipiravir (FAV).